Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages
- PMID: 11060911
- DOI: 10.1177/003693300004500403
Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages
Abstract
The aim of this study was to compare the clinical course and radiological features of oral anticoagulant (OAC)-related intracranial haemorrhages with those of haemorrhages unrelated to OAC use admitted over the last six years to a tertiary care centre in the North of Scotland. We furthermore wished to determine the measures taken for reversal of OAC therapy and the resulting short-term outcome. Sixty-eight patients had been treated with OACs at the time of intracranial haemorrhage (32% subdural, 62% intracerebral). Patients admitted with OAC-related and unrelated haemorrhages did not differ significantly in any of the clinical features considered. On CT scan, there was no significant difference according to OAC use in the mean size of subdural (depth 15 +/- 5 vs. 18 +/- 8 mm, p = 0.36), or intracerebral haematomas (max. diameter 40 +/- 21 vs. 41 +/- 20 mm, p = 0.73). No reversal measures were taken in 38% of OAC-treated patients. In-hospital mortality was significantly higher for OAC-related haemorrhages compared to unrelated haemorrhages (38% vs. 18%, p = 0.001). To further elucidate the effects of anticoagulant reversal on the outcome of OAC-related intracranial haemorrhages, a large-scale prospective study is warranted.
Similar articles
-
Intracerebral haemorrhages and oral anticoagulation in the north of Scotland.Scott Med J. 2000 Aug;45(4):101-4. doi: 10.1177/003693300004500402. Scott Med J. 2000. PMID: 11060910 Review.
-
Reversal treatment and clinical outcomes in acute intracranial haemorrhage associated with oral anticoagulant use: protocol of a planned systematic review and meta-analysis.BMJ Open. 2025 Feb 18;15(2):e090357. doi: 10.1136/bmjopen-2024-090357. BMJ Open. 2025. PMID: 39965957 Free PMC article.
-
Risk analysis of thrombo-embolic and recurrent bleeding events in the management of intracranial haemorrhage due to oral anticoagulation.Acta Chir Belg. 2005 May-Jun;105(3):268-74. doi: 10.1080/00015458.2005.11679715. Acta Chir Belg. 2005. PMID: 16018519
-
Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage.Stroke. 2000 Nov;31(11):2558-62. doi: 10.1161/01.str.31.11.2558. Stroke. 2000. PMID: 11062275
-
Warfarin and intracranial haemorrhage.Blood Rev. 2009 Jan;23(1):1-9. doi: 10.1016/j.blre.2008.05.001. Epub 2008 Jun 25. Blood Rev. 2009. PMID: 18583002 Review.
Cited by
-
Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.Drugs. 2004;64(6):577-95. doi: 10.2165/00003495-200464060-00002. Drugs. 2004. PMID: 15018589 Review.
-
Risk Factors Associated With Mortality and Neurologic Disability After Intracerebral Hemorrhage in a Racially and Ethnically Diverse Cohort.JAMA Netw Open. 2022 Mar 1;5(3):e221103. doi: 10.1001/jamanetworkopen.2022.1103. JAMA Netw Open. 2022. PMID: 35289861 Free PMC article.
-
Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.J Neurol Neurophysiol. 2011;2011:S1-e001. doi: 10.4172/2155-9562.S1-e001. J Neurol Neurophysiol. 2011. PMID: 22400125 Free PMC article.
-
Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage.Clin Med Insights Case Rep. 2011;4:1-6. doi: 10.4137/CCRep.S6433. Epub 2011 Jan 12. Clin Med Insights Case Rep. 2011. PMID: 21769259 Free PMC article.
-
Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review.Int J Emerg Med. 2011 Jul 8;4(1):40. doi: 10.1186/1865-1380-4-40. Int J Emerg Med. 2011. PMID: 21740550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical